Retiro De Equipo (Recall) de ICU Mednet(TM) Medication Management Suite 6.1 and 6.21

Recall

78418

Class 2

Z-0195-2018

2017-10-30

Open, Classified

United States

USFDA

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=159493

Issue 1: the mednet meds 6.1 and 6.21 programs, under certain conditions, can change the piggyback medication entry set settings for existing defined medication entries. this includes (a) whether a medication may be piggybacked and (b) whether an infusion may be interrupted by a piggyback. this only occurs when: 1. medication entries are built with the same displayed name and diluent amount and; 2. the piggyback or interruptible settings differ from one cca to another and; 3. the drug library is exported then imported into the mednet meds program. the changed drug library may then be finalized and downloaded to infusers for use in clinical settings. the changes are made without any notice provided to either the mednet meds user (pharmacist) or to the clinician operating the infuser that the piggyback or interruptible settings have been altered. issue 2: the mednet meds 6.1 program, under certain conditions different from those described above in issue 1, can change the piggyback medication entry set settings for existing defined medication entries. this includes (a) whether a medication may be piggybacked and (b) whether an infusion may be interrupted by a piggyback. this only occurs when: 1. the master drug formulary contains medication entries built with the same displayed name and diluent amounts but one is a limited rule set and the other is a full rule set and; 2. the medication entry built as the full rule set has a blank medication amount with the medication units in mg and; 3. both medication entries have different piggyback options set and; 4. the drug library is exported then imported into the mednet meds program. in this case, the piggyback options will be changed during an import of such drug library.

ICU Medical sent an Urgent : Medical Device Correction letter dated October 30, 2017, Please Inform potential users in your organization of this notification and complete the attached response form and return it to the fax number or e-mail address on the form,even if you do not have the affected product. If you have distributed the product further, notify your accounts that received the product identified above of this notification and ask them to contact Stericycle at 1-855-215-5460 (M-F,8am-5pm ET) to receive a reply form. ICU Medical is committed to patient safety and is focused on providing exceptional product reliability and the highest level of customer satisfaction. Thank you for your prompt support on this important matter. We appreciate your cooperation.